BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Engineer R, Goel M, Chopra S, Patil P, Purandare N, Rangarajan V, Ph R, Bal M, Shrikhande S, Shrivastava SK, Mehta S. Neoadjuvant Chemoradiation Followed by Surgery for Locally Advanced Gallbladder Cancers: A New Paradigm. Ann Surg Oncol 2016;23:3009-15. [DOI: 10.1245/s10434-016-5197-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Y, Li D, You J, Zeng S, Yu W. Hepatopancreatoduodenectomy for Locally Advanced Gallbladder Cancer: Is It Worthwhile? Indian J Surg 2022;84:535-40. [DOI: 10.1007/s12262-022-03471-8] [Reference Citation Analysis]
2 Matsuyama R, Mori R, Ota Y, Homma Y, Yabusita Y, Hiratani S, Murakami T, Sawada Y, Miyake K, Shimizu Y, Kumamoto T, Endo I. Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma. Ann Surg Oncol 2022;29:2393-405. [PMID: 34994885 DOI: 10.1245/s10434-021-11206-4] [Reference Citation Analysis]
3 Miyamoto R, Ogura T, Takahashi A, Ishida H, Matsudaira S, Amikura K, Suzuki Y, Shimizu S, Kihara A, Kanda H, Kawashima Y. Conversion surgery for initially unresectable advanced biliary tract cancer treated with gemcitabine plus cisplatin combination chemotherapy: a case report and literature review. Int Canc Conf J. [DOI: 10.1007/s13691-022-00545-y] [Reference Citation Analysis]
4 Ozer M, Goksu SY, Sanford NN, Porembka M, Khurshid H, Ahn C, Maxwell MC, Beg MS, Kazmi SM. A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer. JAMA Netw Open 2022;5:e2146912. [PMID: 35171262 DOI: 10.1001/jamanetworkopen.2021.46912] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Peng DZ, Nie GL, Li B, Cai YL, Lu J, Xiong XZ, Cheng NS. Prediction of Early Recurrence After R0 Resection for Gallbladder Carcinoma of Stage T1b-T3. Cancer Manag Res 2022;14:37-47. [PMID: 35018120 DOI: 10.2147/CMAR.S342674] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Naveed S, Qari H, Thau CM, Burasakarn P, Mir AW. Neoadjuvant Chemotherapy for Advanced Gallbladder Cancer: Do We have Enough Evidence? A Systematic Review. Euroasian J Hepatogastroenterol 2021;11:87-94. [PMID: 34786362 DOI: 10.5005/jp-journals-10018-1348] [Reference Citation Analysis]
7 Takada N, Sugano H, Shirai Y, Saito N, Hamura R, Taniai T, Uwagawa T, Yanaga K, Ikegami T, Ohashi T, Eto K. Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells. PLoS One 2021;16:e0257019. [PMID: 34473771 DOI: 10.1371/journal.pone.0257019] [Reference Citation Analysis]
8 Bhargava PG, Kumar A, Simha V, Shah M, Patkar S, Goel M, Ostwal V, Ramaswamy A. Presentation and Outcomes with First-Line Chemotherapy in Advanced Cholangiocarcinomas-A Relatively Rare Component of Biliary Tract Cancers in India. South Asian J Cancer 2020;9:209-12. [PMID: 34268260 DOI: 10.1055/s-0041-1726140] [Reference Citation Analysis]
9 Goel M, Gupta AM, Patkar S, Parray AM, Shetty N, Ramaswamy A, Patil P, Chopra S, Ostwal V, Kulkarni S, Engineer R, Mehta S. Towards standardization of management of gallbladder carcinoma with obstructive jaundice: Analysis of 113 cases over 10 years at a single institution. J Surg Oncol 2021;124:572-80. [PMID: 34106475 DOI: 10.1002/jso.26564] [Reference Citation Analysis]
10 Gupta P, Meghashyam K, Marodia Y, Gupta V, Basher R, Das CK, Yadav TD, Irrinki S, Nada R, Dutta U. Locally advanced gallbladder cancer: a review of the criteria and role of imaging. Abdom Radiol (NY) 2021;46:998-1007. [PMID: 32945922 DOI: 10.1007/s00261-020-02756-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
11 Yuza K, Sakata J, Hirose Y, Miura K, Ando T, Katada T, Takizawa K, Kobayashi T, Ichikawa H, Shimada Y, Nagahashi M, Wakai T. Outcome of radical surgery for gallbladder carcinoma according to TNM stage: implications for adjuvant therapeutic strategies. Langenbecks Arch Surg 2021;406:801-11. [PMID: 33398448 DOI: 10.1007/s00423-020-02068-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ramachandran A, Srivastava DN, Madhusudhan KS. Gallbladder cancer revisited: the evolving role of a radiologist. Br J Radiol 2021;94:20200726. [PMID: 33090880 DOI: 10.1259/bjr.20200726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
13 Sugiura R, Kuwatani M, Kato S, Kawakubo K, Kamachi H, Taketomi A, Noji T, Okamura K, Hirano S, Sakamoto N. Risk factors for dysfunction of preoperative endoscopic biliary drainage for malignant hilar biliary obstruction. J Hepatobiliary Pancreat Sci. 2020;27:851-859. [PMID: 32506844 DOI: 10.1002/jhbp.778] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Patkar S, Chaturvedi A, Goel M, Rangarajan V, Sharma A, Engineer R. Role of positron emission tomography-contrast enhanced computed tomography in locally advanced gallbladder cancer. J Hepatobiliary Pancreat Sci 2020;27:164-70. [PMID: 31945262 DOI: 10.1002/jhbp.712] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
15 George G, Lewis S, Chopra S, Phurailatpam R, Engineer R. A Retrospective Study of the Dosimetric Parameters and Duodenal Toxicity in Patients With Upper Gastrointestinal and Gynaecological Cancers Treated With Radiation Therapy. Clinical Oncology 2020;32:e53-9. [DOI: 10.1016/j.clon.2019.08.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
16 Sahara K, Tsilimigras DI, Maithel SK, Abbott DE, Poultsides GA, Hatzaras I, Fields RC, Weiss M, Scoggins C, Isom CA, Idrees K, Shen P, Endo I, Pawlik TM; and the US Extrahepatic Biliary Malignancy Consortium. Survival benefit of lymphadenectomy for gallbladder cancer based on the therapeutic index: An analysis of the US extrahepatic biliary malignancy consortium. J Surg Oncol 2020;121:503-10. [PMID: 31907941 DOI: 10.1002/jso.25825] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
17 Turgeon MK, Maithel SK. Cholangiocarcinoma: a site-specific update on the current state of surgical management and multi-modality therapy. Chin Clin Oncol 2020;9:4. [PMID: 31500433 DOI: 10.21037/cco.2019.08.09] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
18 Engineer R, Patkar S, Lewis SC, Sharma AD, Shetty N, Ostwal V, Ramaswamy A, Chopra S, Agrawal A, Patil P, Mehta S, Goel M. A phase III randomised clinical trial of perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB): study protocol. BMJ Open 2019;9:e028147. [PMID: 31253621 DOI: 10.1136/bmjopen-2018-028147] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ashai N, Prasad P, Rajdev L. Multimodality Management of Localized Biliary Cancer. Curr Treat Options in Oncol 2019;20. [DOI: 10.1007/s11864-019-0655-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Søreide K, Guest RV, Harrison EM, Kendall TJ, Garden OJ, Wigmore SJ. Systematic review of management of incidental gallbladder cancer after cholecystectomy. Br J Surg 2019;106:32-45. [PMID: 30582640 DOI: 10.1002/bjs.11035] [Cited by in Crossref: 36] [Cited by in F6Publishing: 46] [Article Influence: 12.0] [Reference Citation Analysis]
21 Hakeem AR, Papoulas M, Menon KV. The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer – A systematic review. European Journal of Surgical Oncology 2019;45:83-91. [DOI: 10.1016/j.ejso.2018.08.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
22 Gil L, de Aretxabala X, Lendoire J, Duek F, Hepp J, Imventarza O. Incidental Gallbladder Cancer: How Residual Disease Affects Outcome in Two Referral HPB Centers from South America. World J Surg 2019;43:214-20. [DOI: 10.1007/s00268-018-4762-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
23 Patkar S, Ostwal V, Ramaswamy A, Engineer R, Chopra S, Shetty N, Dusane R, Shrikhande SV, Goel M. Emerging role of multimodality treatment in gall bladder cancer: Outcomes following 510 consecutive resections in a tertiary referral center. J Surg Oncol 2018;117:372-9. [DOI: 10.1002/jso.24837] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
24 Ghadyalpatil NS, Supriya C, Prachi P, Ashwin D, Avanish S. Gastrointestinal cancers in India: Treatment perspective. South Asian J Cancer 2016;5:126-36. [PMID: 27606298 DOI: 10.4103/2278-330X.187585] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]